STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more
At AACR, there was talk of Chinese biotech's place in cancer research, oncology’s comms issue, and more.
Read full article →Healthcare Policy
Latest Healthcare Policy news from across the web.
Video: Robert F. Kennedy Jr. testifies before Senate HELP committee
Watch RFK Jr. testify before the Senate's health care panel.
Read full article →Increased calls to 988 hotline associated with a drop in suicides among young people, study finds
Suicide rates among young people dropped 11% after the U.S. launched the 988 national suicide and crisis hotline, a new study shows
Read full article →STAT+: Gene therapy trial for deafness adds evidence to drug’s efficacy
After gene therapy for a rare form of deafness, 90% of participants in a clinical trial in China had significant improvement in hearing.
Read full article →STAT+: The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy
Everything you need to know about biotech today from The Readout newsletter
Read full article →STAT+: Pharmalittle: We’re reading about Medicare’s obesity drug pilot, an experimental Roche MS drug, and more
The Trump administration has dropped a plan for insurers to provide cheap weight loss drugs to seniors through a Medicare pilot program
Read full article →Moderna continues bird flu vax study, but limits work in the U.S.
Flu shot no longer mandated for U.S. troops, "healthy" snacks, and other news from Morning Rounds
Read full article →Opinion: Behind every miracle drug is a story
“In every drug, there is a much larger story to tell about health and medicine and society and business and economics,” says Thomas Goetz.
Read full article →Gene therapy for a rare type of deafness shows lasting results
Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have persisted for more than two years for some patients.
Read full article →Restrictions on obesity drug coverage force patients to pivot
Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.
Read full article →Trump administration delays rule aimed at improving disability access in schools
Schools, colleges and other public institutions originally had until this week to make online content accessible to people with disabilities. Now, the Justice Department has delayed that deadline.
Read full article →Senators grill RFK Jr. on vaccines, drug prices and more at hearing
Health Secretary Robert F. Kennedy Jr. faced tough questioning as he caps off seven hearings on the Hill in as many days. It's the first time he has testified before Congress since September.
Read full article →